zelapar

Generic: selegiline hydrochloride

Labeler: bausch health us, llc
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name zelapar
Generic Name selegiline hydrochloride
Labeler bausch health us, llc
Dosage Form TABLET, ORALLY DISINTEGRATING
Routes
ORAL
Active Ingredients

selegiline hydrochloride 1.25 mg/1

Manufacturer
Bausch Health US, LLC

Identifiers & Regulatory

Product NDC 0187-0453
Product ID 0187-0453_f8d8f532-d8a6-4eff-baab-325fed820cdb
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA021479
Listing Expiration 2026-12-31
Marketing Start 2006-06-14

Pharmacologic Class

Classes
monoamine oxidase inhibitor [epc] monoamine oxidase inhibitors [moa] monoamine oxidase type b inhibitor [epc] monoamine oxidase-b inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 01870453
Hyphenated Format 0187-0453

Supplemental Identifiers

RxCUI
859190 859192
UNII
6W731X367Q

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name zelapar (source: ndc)
Generic Name selegiline hydrochloride (source: ndc)
Application Number NDA021479 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 1.25 mg/1
source: ndc
Packaging
  • 6 POUCH in 1 CARTON (0187-0453-02) / 10 TABLET, ORALLY DISINTEGRATING in 1 POUCH
source: ndc

Packages (1)

0187-0453-02 6 POUCH in 1 CARTON (0187-0453-02) / 10 TABLET, ORALLY DISINTEGRATING in 1 POUCH

Ingredients (1)

selegiline hydrochloride (1.25 mg/1)

Linked Drug Pages (1)

ZELAPAR ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "f8d8f532-d8a6-4eff-baab-325fed820cdb", "openfda": {"unii": ["6W731X367Q"], "rxcui": ["859190", "859192"], "spl_set_id": ["380d7717-2a79-42f3-a712-efe5e7696ba0"], "manufacturer_name": ["Bausch Health US, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "6 POUCH in 1 CARTON (0187-0453-02)  / 10 TABLET, ORALLY DISINTEGRATING in 1 POUCH", "package_ndc": "0187-0453-02", "marketing_start_date": "20060614"}], "brand_name": "ZELAPAR", "product_id": "0187-0453_f8d8f532-d8a6-4eff-baab-325fed820cdb", "dosage_form": "TABLET, ORALLY DISINTEGRATING", "pharm_class": ["Monoamine Oxidase Inhibitor [EPC]", "Monoamine Oxidase Inhibitors [MoA]", "Monoamine Oxidase Type B Inhibitor [EPC]", "Monoamine Oxidase-B Inhibitors [MoA]"], "product_ndc": "0187-0453", "generic_name": "SELEGILINE HYDROCHLORIDE", "labeler_name": "Bausch Health US, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ZELAPAR", "active_ingredients": [{"name": "SELEGILINE HYDROCHLORIDE", "strength": "1.25 mg/1"}], "application_number": "NDA021479", "marketing_category": "NDA", "marketing_start_date": "20060614", "listing_expiration_date": "20261231"}